Earnings call transcript: Troax Group posts record Q2 2026 order growth

Troax reported Q2 order intake up 51% YoY to EUR 98.3m and sales up 23% YoY to EUR 84.2m, with adjusted EBITA of EUR 10.9m and a steady 13.0% margin despite U.S. transition costs. Management highlighted North America’s 84% organic order growth and expects improved operating cash flow in 2H and net debt to trend toward a 2.5x target by year-end (amid net debt rising to 3.3x after the May dividend and an EUR 11m earn-out revaluation). Shares were up 0.88% to $16.08 near the top of the 52-week range, reflecting modestly positive investor reaction to growth and margin progress.

Analysis

The market is probably still underpricing the operating leverage here. The important read-through is not the headline growth rate, but that mix is shifting toward longer-cycle projects where revenue recognition lags orders; that creates a second-half catch-up in margins and cash conversion if execution holds. That dynamic tends to matter most for suppliers tied to data-center buildouts and warehouse automation, while more cyclically exposed industrial names with auto-heavy mix can lag as budget discipline stays tight.

The near-term risk is balance-sheet optics. At this leverage point, any slippage in shipment timing or a pause in hyperscaler/warehouse capex could keep net debt elevated and prevent the rerating investors are implicitly paying for. The key falsifier over the next 1-3 months is simple: if Q3 does not show cleaner cash conversion and leverage trending down, the thesis shifts from "self-help inflection" to "growth financed by working capital."

Contrarian view: the consensus is probably too focused on acquisition contribution and too dismissive of organic momentum. If backlog is real, the bigger surprise is not top-line, but sustained margin improvement once temporary plant-transition friction disappears; that is a 6-18 month compounding story, not a one-quarter event. The move may be only partially reflected because the stock market is rewarding the growth narrative, but not yet fully discounting the earnings power if the company hits its year-end efficiency targets.

Key Decisions for Investors

• Long ABB / short STLA for 1-3 months: express the divergence between data-center/warehouse capex strength and persistent auto weakness. Risk/reward is best if European industrial ordering stays firm; stop if auto order books stabilize or ABB guides conservatively.
• Buy XLI on a 1-2% pullback as a 3-6 month proxy for U.S. industrial capex re-acceleration. Use ISM new orders and industrial earnings guidance as the falsifier; cut if those roll over.
• Avoid chasing the small-cap industrial after the quarter; instead set an alert for Q3 leverage and operating cash flow. If net debt/EBITDA does not move meaningfully toward 3.0x by year-end, expect multiple compression rather than further rerating.
• If you want direct exposure to the same theme, add a starter long in data-center infrastructure beneficiaries only on weakness, not strength; the trade works best if hyperscaler capex stays intact and warehouse demand remains broad-based.